Researchers at Memorial Sloan Kettering Cancer Center have developed a training program to help health providers reduce lung cancer stigma. In this interview, they discuss an ongoing NCI-funded nationwide clinical trial to test the training.
Researchers have found that feeding fructose, a main component of high-fructose corn syrup, to lab animals with cancer made their tumors grow faster. But the tumors couldn’t directly consume the sugar—it had to take a detour through the liver first. 
FDA’s approvals of Darzalex Faspro and Sarclisa, each used in combination with standard three-drug treatment regimens, should change the initial treatment of newly diagnosed multiple myeloma, including for patients who can’t get a stem cell transplant.
In a small clinical trial, an experimental CAR T-cell therapy that targets the protein GD2 on cancer cells shrank tumors—for 2 years or more in several cases—in children and young adults with diffuse midline glioma, an aggressive brain and spinal cord cancer.